An official website of the United States government
Plant diseases are one of the grand challenges that face the agriculture sector worldwide. In the United States, crop diseases cause losses of one-third of crop production annually. Despite the importance, crop disease diagnosis is challenging for limited-resources farmers if performed through optical observation of plant leaves’ symptoms. Therefore, there is an urgent need for markedly improved detection, monitoring, and prediction of crop diseases to reduce crop agriculture losses. Computer vision empowered with Machine Learning (ML) has tremendous promise for improving crop monitoring at scale in this context. This paper presents an ML-powered mobile-based system to automate the plant leaf disease diagnosis process. The developed system uses Convolutional Neural networks (CNN) as an underlying deep learning engine for classifying 38 disease categories. We collected an imagery dataset containing 96,206 images of plant leaves of healthy and infected plants for training, validating, and testing the CNN model. The user interface is developed as an Android mobile app, allowing farmers to capture a photo of the infected plant leaves. It then displays the disease category along with the confidence percentage. It is expected that this system would create a better opportunity for farmers to keep their crops healthy and eliminate the use of wrong fertilizers that could stress the plants. Finally, we evaluated our system using various performance metrics such as classification accuracy and processing time. We found that our model achieves an overall classification accuracy of 94% in recognizing the most common 38 disease classes in 14 crop species.
more »
« less
This content will become publicly available on July 19, 2025
An Artificial Intelligence Driven Approach for Classification of OphthalmicImages using Convolutional Neural Network: An Experimental Study
Background:Early disease detection is emphasized within ophthalmology now more than ever, and as a result, clinicians and innovators turn to deep learning toexpedite accurate diagnosis and mitigate treatment delay. Efforts concentrate on the creation of deep learning systems that analyze clinical imagedata to detect disease-specific features with maximum sensitivity. Moreover, these systems hold promise of early accurate diagnosis and treatmentof patients with common progressive diseases. DenseNet, ResNet, and VGG-16 are among a few of the deep learning Convolutional NeuralNetwork (CNN) algorithms that have been introduced and are being investigated for potential application within ophthalmology. Methods:In this study, the authors sought to create and evaluate a novel ensembled deep learning CNN model that analyzes a dataset of shuffled retinal colorfundus images (RCFIs) from eyes with various ocular disease features (cataract, glaucoma, diabetic retinopathy). Our aim was to determine (1) therelative performance of our finalized model in classifying RCFIs according to disease and (2) the diagnostic potential of the finalized model toserve as a screening test for specific diseases (cataract, glaucoma, diabetic retinopathy) upon presentation of RCFIs with diverse diseasemanifestations. Results:We found adding convolutional layers to an existing VGG-16 model, which was named as a proposed model in this article that, resulted insignificantly increased performance with 98% accuracy (p<0.05), including good diagnostic potential for binary disease detection in cataract,glaucoma, diabetic retinopathy. Conclusion:The proposed model was found to be suitable and accurate for a decision support system in Ophthalmology Clinical Framework.
more »
« less
- Award ID(s):
- 2231200
- PAR ID:
- 10571780
- Editor(s):
- Kim, Euishin E
- Publisher / Repository:
- Benthan Science
- Date Published:
- Journal Name:
- Current Medical Imaging Reviews
- Volume:
- 20
- ISSN:
- 1573-4056
- Subject(s) / Keyword(s):
- Artificial intelligence Deep learning Ocular disease Detection Diagnosis Algorithms
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
Plasma cell-free DNA (cfDNA) is a noninvasive biomarker for cell death of all organs. Deciphering the tissue origin of cfDNA can reveal abnormal cell death because of diseases, which has great clinical potential in disease detection and monitoring. Despite the great promise, the sensitive and accurate quantification of tissue-derived cfDNA remains challenging to existing methods due to the limited characterization of tissue methylation and the reliance on unsupervised methods. To fully exploit the clinical potential of tissue-derived cfDNA, here we present one of the largest comprehensive and high-resolution methylation atlas based on 521 noncancer tissue samples spanning 29 major types of human tissues. We systematically identified fragment-level tissue-specific methylation patterns and extensively validated them in orthogonal datasets. Based on the rich tissue methylation atlas, we develop the first supervised tissue deconvolution approach, a deep-learning-powered model, cfSort , for sensitive and accurate tissue deconvolution in cfDNA. On the benchmarking data, cfSort showed superior sensitivity and accuracy compared to the existing methods. We further demonstrated the clinical utilities of cfSort with two potential applications: aiding disease diagnosis and monitoring treatment side effects. The tissue-derived cfDNA fraction estimated from cfSort reflected the clinical outcomes of the patients. In summary, the tissue methylation atlas and cfSort enhanced the performance of tissue deconvolution in cfDNA, thus facilitating cfDNA-based disease detection and longitudinal treatment monitoring.more » « less
-
Alterations in ocular blood flow have been identified as important risk factors for the onset and progression of numerous diseases of the eye. In particular, several population-based and longitudinal-based studies have provided compelling evidence of hemodynamic biomarkers as independent risk factors for ocular disease throughout several different geographic regions. Despite this evidence, the relative contribution of blood flow to ocular physiology and pathology in synergy with other risk factors and comorbidities (e.g., age, gender, race, diabetes and hypertension) remains uncertain. There is currently no gold standard for assessing all relevant vascular beds in the eye, and the heterogeneous vascular biomarkers derived from multiple ocular imaging technologies are non-interchangeable and difficult to interpret as a whole. As a result of these disease complexities and imaging limitations, standard statistical methods often yield inconsistent results across studies and are unable to quantify or explain a patient's overall risk for ocular disease. Combining mathematical modeling with artificial intelligence holds great promise for advancing data analysis in ophthalmology and enabling individualized risk assessment from diverse, multi-input clinical and demographic biomarkers. Mechanism-driven mathematical modeling makes virtual laboratories available to investigate pathogenic mechanisms, advance diagnostic ability and improve disease management. Artificial intelligence provides a novel method for utilizing a vast amount of data from a wide range of patient types to diagnose and monitor ocular disease. This article reviews the state of the art and major unanswered questions related to ocular vascular anatomy and physiology, ocular imaging techniques, clinical findings in glaucoma and other eye diseases, and mechanistic modeling predictions, while laying a path for integrating clinical observations with mathematical models and artificial intelligence. Viable alternatives for integrated data analysis are proposed that aim to overcome the limitations of standard statistical approaches and enable individually tailored precision medicine in ophthalmology.more » « less
-
Alterations in ocular blood flow have been identified as important risk factors for the onset and progression of numerous diseases of the eye. In particular, several population-based and longitudinal-based studies have provided compelling evidence of hemodynamic biomarkers as independent risk factors for ocular disease throughout several different geographic regions. Despite this evidence, the relative contribution of blood flow to ocular physiology and pathology in synergy with other risk factors and comorbidities (e.g., age, gender, race, diabetes and hypertension) remains uncertain. There is currently no gold standard for assessing all relevant vascular beds in the eye, and the heterogeneous vascular biomarkers derived from multiple ocular imaging technologies are non-interchangeable and difficult to interpret as a whole. As a result of these disease complexities and imaging limitations, standard statistical methods often yield inconsistent results across studies and are unable to quantify or explain a patient's overall risk for ocular disease. Combining mathematical modeling with artificial intelligence holds great promise for advancing data analysis in ophthalmology and enabling individualized risk assessment from diverse, multi-input clinical and demographic biomarkers. Mechanism-driven mathematical modeling makes virtual laboratories available to investigate pathogenic mechanisms, advance diagnostic ability and improve disease management. Artificial intelligence provides a novel method for utilizing a vast amount of data from a wide range of patient types to diagnose and monitor ocular disease. This article reviews the state of the art and major unanswered questions related to ocular vascular anatomy and physiology, ocular imaging techniques, clinical findings in glaucoma and other eye diseases, and mechanistic modeling predictions, while laying a path for integrating clinical observations with mathematical models and artificial intelligence. Viable alternatives for integrated data analysis are proposed that aim to overcome the limitations of standard statistical approaches and enable individually tailored precision medicine in ophthalmology.more » « less
-
Abstract Alzheimer’s Disease (AD) is a progressive neurodegenerative disease and the leading cause of dementia. Early diagnosis is critical for patients to benefit from potential intervention and treatment. The retina has emerged as a plausible diagnostic site for AD detection owing to its anatomical connection with the brain. However, existing AI models for this purpose have yet to provide a rational explanation behind their decisions and have not been able to infer the stage of the disease’s progression. Along this direction, we propose a novel model-agnostic explainable-AI framework, called Granu$$\underline{la}$$ r Neuron-le$$\underline{v}$$ el Expl$$\underline{a}$$ iner (LAVA), an interpretation prototype that probes into intermediate layers of the Convolutional Neural Network (CNN) models to directly assess the continuum of AD from the retinal imaging without the need for longitudinal or clinical evaluations. This innovative approach aims to validate retinal vasculature as a biomarker and diagnostic modality for evaluating Alzheimer’s Disease. Leveraged UK Biobank cognitive tests and vascular morphological features demonstrate significant promise and effectiveness of LAVA in identifying AD stages across the progression continuum.more » « less
